• About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Board Members
    • Management Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Contact
World TB Day 2020

World TB Day 2020

#ItsTimeToEndTB: Diagnostics are critical in infectious disease control

Written by Dr Sean Parsons, CEO Ellume.

As the world rallies to curb the spread of COVID-19, this year’s World Tuberculosis Day serves as a stark reminder that the two major biological threats to humans are pandemic viruses (like COVID-19) and tuberculosis (TB) – especially multi-drug resistant TB.

We at Ellume are doing our part in responding to COVID-19 (major announcements to come shortly), but when the COVID threat has eventually passed, we must not forget that we must continue the fight against TB.

On this day 118 years ago, Dr Robert Koch successfully identified the bacteria responsible for causing TB, paving the way for the prevention and control of this deadly disease. It was an important breakthrough in combating a disease that was once one of the most urgent health problems facing the world. Yet a century later with a death rate of 1.5 million people every year, more people will die today from TB than COVID-19.

We all now appreciate that diagnostics are crucial in responding to pandemic viruses, but they are also the key for responding to TB.

At Ellume, our diagnostics platform means we haven an important role to play in the fight against these common infectious diseases. By combining our technology with QIAGEN’s market leading test we have created QuantiFERON® TB Access, an accurate, rapid diagnostic designed for use in moderate and high burden countries. It has the ability to diagnose cases with greater speed and accuracy and overcome the limitations of a lack of infrastructure and shortage of trained technicians. The product can perform up to eight non-invasive tests simultaneously without computer access or a continuous power supply. Together with QIAGEN we are striving to make QuantiFERON® TB Access available later this year.

While we have a long way to go until TB is eradicated, we’re proud that our technology holds the key to bringing faster and more accurate diagnostics to the people who need it most.

#ItsTimeToEndTB

#EndTB #WorldTBDay

Learn about QuantiFERON-Access here.
Learn about Ellume here.

Recent Posts
  • Over-the-counter COVID-19 testing now available at CVS Pharmacy
  • Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
  • U.S. strikes $230 million deal for over-the-counter Covid tests
  • A fast, at-home coronavirus test will be available to Americans this year
  • U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests
Archives
Categories
Business

Ellume appoints Joanne Moss to its Board as Non-executive Director

Previous thumb

Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Next thumb
Scroll

ellume logo white

ABN 13 141 767 660
57 Didsbury Street,
East Brisbane, Queensland 4169
Australia

MENU

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

CONTACT US

Corporate / General Enquiries:
+61 7 3393 1448
Sales / Product Enquiries:
+61 7 3393 1448 (outside the U.S.)
1-888-885-6121 (within U.S.)
Email Enquiries
Terms of Use
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance – NOT AVAILABLE FOR SALE © Ellume Limited 2020